SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is actively trending as its community anticipates a significant price movement, fueled by discussions around potential technical breakouts and its established identity as "digital silver." Traders are pointing to charting patterns and periods of consolidation, suggesting a substantial rally is on the horizon for the long-standing cryptocurrency.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending due to its live integration with Bridge, a Stripe company, enabling seamless fiat on/off-ramps for USD and EUR and directly connecting to regulated banking systems. The community is highlighting its compliance-first architecture and validated throughput of over eleven million transactions per second, positioning it as an undervalued Layer 1 infrastructure play for institutional flows and cross-chain settlements. This signifies a crucial step in bridging traditional finance with the crypto ecosystem.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending amidst significant developments, including the debut of a new Grayscale ETF and robust adoption of its Cross-Chain Interoperability Protocol by major financial institutions for Real World Asset tokenization. The community is buzzing about LINK's crucial role as foundational infrastructure, yet sentiment remains divided regarding its price performance compared to its ongoing fundamental growth and emerging complementary networks.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Silver Corp

Americas Silver Corp is trending as physical silver prices continue their explosive ascent, fueling community discussion around a growing disconnect with paper markets and a looming "silver squeeze." Investors are keenly focused on the company's strategic position as the sole U.S. antimony producera critical strategic metalalong with recent high-grade mine acquisitions and significant operational upgrades at its Galena complex.

Hyperlane is an open-source, permissionless framework for blockchain interoperability. Today, it connects over 170 blockchains and supports 5+ virtual machines, powering hundreds of interchain applications on a daily basis—from asset bridges and cross-chain governance to emerging DeFi use cases. But beyond its current role as an interchain messaging protocol, we see Hyperlane evolving into a global network for transferring value—a decentralized infrastructure layer that would serve as the technical backbone of a modern digital payment network.

Hyperchain

Hyper Crypto is actively trending amidst a strong community debate, driven by its positioning as a gaming utility token with an ambitious all-in-one platform for tournaments, streaming, and NFTs. While many express bullish sentiment on its low supply and potential for significant price movements, others vocalize skepticism regarding the project's transparency and past performance, particularly concerning its token migration.

Ethereum Classic

Ethereum Classic ($ETC) is trending amidst widespread community frustration regarding its persistent low price and perceived underperformance compared to other major cryptocurrencies. Despite this, a significant number of holders express strong conviction in its long-term potential, actively discussing current levels as a key 'buy the dip' opportunity in anticipation of a substantial future rally.

Decentraland

Decentraland is experiencing a notable surge in community interest, fueled by its ongoing metaverse events, including its Music Festival and Fashion Week, which showcase continued platform development. Traders are actively discussing the potential for mass adoption and significant price appreciation, with some speculating about major tech partnerships. As a leading metaverse platform, MANA is trending amidst broader optimism for Web3 gaming tokens.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnight ($NIGHT) is experiencing heightened interest driven by its recent "Glacier Drop" airdrop and major exchange listings, contributing to a substantial surge in trading volume. The community is actively discussing its innovative "rational privacy" framework, which aims to balance user privacy with regulatory compliance, positioning it as a key player within the broader Cardano ecosystem for institutional adoption.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is trending amid escalating market interest in its commercialization of Neffy, an epinephrine nasal spray, highlighted by accelerating revenue growth and expanding global approvals. Community discussions frequently point to high short interest, fueling speculation about a potential squeeze, while also vigorously debating Neffy's competitive positioning against upcoming rival Anaphylm in the needle-free anaphylaxis treatment market.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain (VET) is trending amid widespread community frustration over its prolonged underperformance and recent price declines, with many questioning its future trajectory despite its established partnerships and ongoing development. While some long-term holders express deep disappointment, others remain cautiously optimistic, continuing to accumulate and anticipate a significant breakout during a broader altcoin market resurgence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced that...

PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial

PLSE has secured FDA IDE approval to launch its nPulse AF ablation study.

Pulse Biosciences (NASDAQ:PLSE) Trading Up 5% - Here's What Happened

Pulse Biosciences (NASDAQ:PLSE) Trading 5% Higher - Time to Buy...

PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor

Pulse Biosciences partners with MD Anderson to study its nPulse technology for treating benign and malignant thyroid tumors upon receiving FDA approval for a first-in-human trial.

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse Technology

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the Company or Pulse Biosciences), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or...

Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month Low - Here's What Happened

Pulse Biosciences (NASDAQ:PLSE) Reaches New 12-Month Low - Time to Sell...

Pulse Biosciences is Now Oversold (PLSE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Pulse Biosciences (NASDAQ:PLSE) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Pulse Biosciences (NASDAQ:PLSE - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts...

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced plans...

Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates

Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +6.45% and -82.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.32	--	--	N/A
Q3 '25	-$0.31	-$0.20	34.57%	BEAT
Q2 '25	-$0.26	-$0.20	23.53%	BEAT
Q1 '25	--	-$0.17	--	N/A
Q4 '24	--	-$0.17	--	N/A

PLSE
Pulse Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PLSE News

PLSEPulse Biosciences Inc